Keyword: Dermira

News

Lilly Boosts Dermatology with Dermira Buy

15.01.2020 - Eli Lilly has agreed to pay around $1.1 billion cash to buy Dermira, a biopharma focused on developing therapies for chronic skin conditions. The acquisition will add lebrikizumab...

News

Dermira Takes Rights to Roche’s Dermatitis Drug

16.08.2017 - US biotech Dermira has agreed to license certain rights from Swiss drugmaker Roche and its subsidiary Genentech for the investigational atopic dermatitis drug, lebrikizumab. The...